Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02544984 · ClinicalTrials.gov registry record · NA

The Anti-inflammatory Effect of Prophylactic Macrolides on Children With Chronic Lung Disease

A NA study, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT02544984: Completed NA study, sponsored by The University of Texas Health Science Center, Houston.

NCT02544984 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02544984, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The purpose of this study is to determine if the prophylactic use of azithromycin will reduce the total number of days when unscheduled treatment is given outside of the home in a clinic, urgent care, emergency room or hospital setting between the respiratory illness season months (October 1-March 31) and subsequent 2 month follow-up (April and May)

Primary Outcome

Participants were observed for a minimum of 5 months and a maximum of 8 months, depending on when study enrollment occurred. Patients were recruited for this study on a rolling basis during the start of the winter season and then completed the intervention at the same time at the end of the winter season, which accounts for the variability in the amount of time participants were observed.

Interventions

  • DRUG placebo
  • DRUG Azithromycin

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2015-10
Est. Completion 2017-03-31
Phase NA

What the finished NCT02544984 record still lists

NCT02544984 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.

NCT02544984 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02544984 about?

NCT02544984 is a clinical study titled "The Anti-inflammatory Effect of Prophylactic Macrolides on Children With Chronic Lung Disease". The purpose of this study is to determine if the prophylactic use of azithromycin will reduce the total number of days when unscheduled treatment is given outside of the home in a clinic, urgent care, emergency room or hospital setting between the respiratory illness season months (October 1-March 3...

What is the current status of trial NCT02544984?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2015-10. Estimated completion is 2017-03-31.

What interventions are being tested in trial NCT02544984?

The interventions under investigation include: placebo (DRUG), Azithromycin (DRUG).

Who is sponsoring clinical trial NCT02544984?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02544984's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02544984, the US trial registry maintained by the National Library of Medicine. NCT02544984 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.